Application Note: Separation of Recombinant Human Erythropoietin Using Agilent Bio SEC-3
19 July 2012

This application note presents a method for the separation of various recombinant human erythropoietin (EPO) sizes. The HPLC separation of EPO protein can be achieved by using a variety of chemistries, this note focuses on the use of analytical size exclusion using Agilent Bio-SEC columns in combination with the Agilent 1260 Infinity Bio-inert Quaternary HPLC. Methods are optimized for flow rates, gradient and reproducibility under neutral conditions that contain just sodium phosphate buffer.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions


Already a member?

Log in for full access to the article




Remember me